Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abstinence syndrome
addiction, heroin
addiction, heroin-neurologic complications with
advances in neurology
adverse drug reaction
aggression
agitation
alcohol
alcohol, neurologic complications with
alcoholic withdrawal states, DT's, convulsions, etc.
alcoholism
algorithm
allodynia
amphetamines
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, treatment of
analgesic
anesthesia, general
anesthesia, local
anger
antibiotics
antibiotics, neurologic complications with
anticholinesterase
anticonvulsants
anticonvulsants, bioavailability
anticonvulsants, discontinuation in seizure-free epileptics
anticonvulsants, dosage
anticonvulsants, loading dose
anticonvulsants, metabolism
anticonvulsants, parenteral administration
anticonvulsants, pharmacokinetics
anticonvulsants, rate of administration
anticonvulsants, selection of
anticonvulsants, untoward effects of
antidepressant
antiemetic
anxiety
anxiolytic agents
aphasia
aphasia, progressive
autoantibodies
autoimmune disease
autoimmune epilepsy
baclofen
barbiturate anesthesia
bath salts, psychoactive
behavioral disorder
benzodiazepine
beta adrenergic blocker
botulinum toxin
butorphenol
camphor
cannabinoids
cannabis withdrawal syndrome
capsaicin
central nervous system, infection of
cerebral cortical atrophy
cerebrospinal fluid, gammaglobulin of
cerebrovascular accident
cerebrovascular accident, seizure with
chasing the dragon
children
chlorambucil
clonidine
cluster headache
cocaine
cognition
complications
concussive convulsions
confusion
contrast agents, neurotoxicity of
cost effectiveness
cranial neuropathy, multiple
cry, abnormal
cry, high-pitched
cyclic vomiting
cyclosporine
delay in diagnosis
delirium
depression
dermatomyositis
desipramine
detoxification
DHE
diagnostic criteria
dilantin
dilantin, intravenous
dilantin, toxicity
dizziness
drug abuse
drug abuse, neurologic complications of
drug abuse, toxic screen In
drug addiction
drug dependence
drug induced neurologic disorders
drug interactions
drug overdose
drug withdrawal
eclampsia
efficacy
electrolyte imbalance
emergencies, neurologic
encephalitis
encephalitis, autoimmune
encephalitis, focal
encephalitis, Rasmussen's
encephalopathy
encephalopathy, metabolic
endocarditis
ephedrine
epidemiology of neurology
ergonovine
ergotamine
fatigue
feeding disorder
fever
folic acid
fortification spectra
fosphenytoin
gabapentin
gammaglobulin therapy, intravenous
glutamic acid decarboxylase, antibody
Guillain Barre syndrome
head circumference and brain development
head injury
headache
headache, drug induced
headache, intractable
headache, rebound
headache, retro-orbital
headache, severe
headache, treatment of
hemiparesis
human immunodeficiency virus type 1
hyperbaric oxygen
hyperbaric treatment
hypertonia
hyponatremia
hypotension, systemic
iatrogenic neurologic disorders
immunomodulation
immunosuppressive agents
immunotherapy
inclusion body myositis
infection
injection, intramuscular
intellectual deterioration
internuclear ophthalmoplegia
intracerebral hemorrhage
intranasal medication
intrauterine
intravenous
irritability
ketamine
lamotrigine
leukoencephalopathy
levetiracetam
lidocaine
lidocaine, intranasal
lidocaine, intravenous
lifestyle
limbic encephalitis
lorazepam
low birth weight
magnetic stimulation, brain
marihuana
marihuana, bad trips with
marijuana, medical
medical-legal aspects of neurology
memory, impairment of
mental status, abnormal
methadone
mexiletine
microcephaly
midazolam
migraine
migraine, foods causing
migraine, intractable
migraine, premonitory symptoms
migraine, prophylaxis
migraine, treatment of
migraine, triggers
mononeuropathy
morphine
mortality
MRI
MRI, abnormal
MRI, negative
myasthenia gravis
myasthenia gravis, treatment of
myelitis
myelopathy
myoclonic jerks
myoclonus, epilepsy
myopathy
myositis
nalidixic acid
naloxone
naltrexone
narcotic analgesics
nasal spray
nasal stuffiness
nausea and vomiting
neck pain
neonatal abstinence syndrome
neoplasm, intracranial, differential diagnosis of
neoplasm, primary of CNS
neuroleptic
neurologic complications
neurologic consultation
neurologic disease, diagnoses of
neuropathy
neuropathy, etiologies of
neuropathy, motor, multifocal
neuropathy, painful
neuropathy, peripheral, treatment
neuropharmacology
neurotoxin
NMDA antagonists
nonsteroidal anti-inflammatory drug
nortriptyline
old age, neurology of
opiate
out-of-hospital emergency care
oxycodone
oxygen therapy
pain
pain, management of chronic
pain, neuropathic
panic attacks
paramedic
penicillin
personality change
petit mal status
phencyclidine poisoning
phenobarbital
phenylpropanolamine
phonophobia
photophobia
physostigmine
polymyositis
polyneuropathy
polyneuropathy, chronic inflammatory demyelinating
post herpetic neuralgia
potassium channel antibodies
practice guidelines
pregnancy, neurologic complications in
prevention of neurologic disorders
prognosis
propofol
propranolol
psychosis
psychotic behavior
purple glove syndrome
purple hands
quality of life
Red flags
review article
risk factors
safety
screening
sedation
seizure
seizure, acute symptomatic
seizure, adult onset
seizure, age of onset
seizure, brain tumors assoc.with
seizure, children
seizure, classification of
seizure, diagnosis of
seizure, drug resistance
seizure, drug-induced
seizure, elderly
seizure, etiology of
seizure, focal
seizure, intractable
seizure, intractable, treatment of
seizure, post traumatic
seizure, precipitating factors
seizure, pregnancy
seizure, prevention of
seizure, prognosis in adults
seizure, prognosis in childhood
seizure, psychomotor-temporal lobe
seizure, risk factors for
seizure, stimulus sensitive
seizure, systemic disease causing
seizure, treatment of
seizure, withdrawal
seizure, workup of
septicemia
sleep pathology and physiology
sodium valproate
sodium valproate, intravenous
status epilepticus
status epilepticus, intractable
status epilepticus, myoclonic
status epilepticus, nonconvulsive
status epilepticus, out-of-hospital emergency care
steroid therapy, CNS treatment and complications with
stimulant drugs
subarachnoid hemorrhage
sweating
sympathomimetic drugs
systemic lupus erythematosus
systemic lupus erythematosus, neurologic complications with
toxic encephalopathy
treatment of neurologic disorder
tremor
tricyclic antidepressant
triptans
valium
vasculitides
vitamin K
vomiting, intractable
word-finding difficulty
yawning movements
Showing articles 500 to 550 of 2784 << Previous Next >>

HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
NEJM 364:1126-1133, Chen,P.,et al, 2011

Newer-Generation Antiepileptic Drugs and the Risk of Major Birth Defects
JAMA 305:1996-2002, Molgaard, D. & Hviid, A., 2011

Immune Reconstitution Inflammatory Syndrome in Natalizumab-Associated PML
Neurol 77:1061-1067,1033, Tan, I.L.,et al, 2011

Clinical Reasoning: A 34-year-old man with recurrent limb weakness
Neurol 77:e68-e72, Karam, C.,et al, 2011

Responsive Cortical Stimulation for the Treatment of Medically Intractable Partial Epilepsy
Neurol 77:1295-1304,e79, Morrell, M.J.,et al, 2011

Intraventricular Fibrinolysis Versus External Ventricular Drainage Alone in Intraventricular Hemorrhage
Stroke 42:2776-2781, Gaberel, T.,et al, 2011

Low-Dose Recombinant Tissue-Type Plasminogen Activator Enhances Clot Resolution in Brain Hemorrhage
Stroke 42:3009-3016,2999, Naff, N.,et al, 2011

The Cost-Effectiveness of Telestroke in the Treatment of Acute Ischemic Stroke
Neurol 77:1590-1598, Nelson, R.E.,et al, 2011

Fetal Effects of Anticonvulsant Polytherapies
Arch Neurol 68:1273-1279, Holmes, L.et al, 2011

Failure to Take Antiepileptic Drugs as Prescribed
Arch Neurol 68:1318-1320, Modur, P.N., 2011

Seizure Recurrence After Antiepileptic Drug Withdrawal and the Implications for Driving: Further Results from the MRC Antiepileptic Drug Withdrawal Study and a Systematic Review
JNNP 82:1328-1333, Bonnett, L.J.,et al, 2011

Intravenous Dihydroergotamine for Inpatient Management of Refractory Primary Headaches
Neurol 77:1827-1832, Nagy, A.J.,et al, 2011

Relationship Between Chronic Atrial Fibrillation and Worse Outcomes in Stroke Patients After Intravenous Thrombolysis
Arch Neurol 68:1454-1458, Seet, R.C.S.,et al, 2011

Thrombolytic Treatment of Patients with Acute Ischemic Stroke Related to Underlying Arterial Dissection in the United States
Arch Neurol 68:1536-1542, Qureshi, A.I.,et al, 2011

Intraventricular Hemorrhage
UpToDate, Sept, Cucchiara B.L. and Pacelli, J.P., 2011

Subtherapeutic International Normalized Ratio in Warfarin-Treated Patients Increases the Risk for Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis
Stroke 42:2333-2335, Seet, R.C.S.,et al, 2011

Impact of Obesity on Stroke Outcome After Intravenous Thrombolysis
Stroke 42:2330-2332, Sarikaya, H.,et al, 2011

Efficacy of Intravenous Tissue-Type Plasminogen Activator in Central Retinal Artery Occlusion Report From a Randomized, Controlled Trial
Stroke 42:2229-2234, Chen, C.S.,et al, 2011

Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis
Neurol 77:341-348, Strbian, D.,et al, 2011

Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy
NEJM 365:285-287, Egan, A.,et al, 2011

Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurence
Stroke 42:2509-2514, Broderick, J.,et al, 2011

Advanced Brain Imaging Studies Should Be Performed in Patients With Suspected Stroke Presenting Within 4.5 Hours of Symptom Onset
Stroke 42-2666-2667,2670, Parsons, M.W., 2011

Advanced Brain Imaging Studies Should Not Be Performed in Patients With Suspected Stroke Presenting Within 4.5 Hours of Symptom Onset
Stroke 42:2668-2669,2670, Lyden, P.D., 2011

Safety and Functional Outcome of Thrombolysis in Dissection-Related Ischemic Stroke A Meta-Analysis of Individual Patient Data
Stroke 42:2515-2520, Zinkstok, S.M.,et al, 2011

Effects of Extending the Time Window of Thrombolysis to 4.5 Hours Observations in the Swedish Stroke Register (Riks-Stroke)
Stroke 42:2492-2497, Asplund, K.,et al, 2011

Assessing Bioequivalence of Generic Antiepilepsy Drugs
Ann Neurol 70:221-228,192, Krauss, G.L.,et al, 2011

Encephalitis Associated with Glutamic Acid Decarboxylase Autoantibodies in a Child A Treatable Condition?
Arch Neurol 68:1065-1068, Korff, C.M.,et al, 2011

An Acutely Confused Young Woman
Lancet 378-456, Casetta, I,.et al, 2011

Drug-Resistant Epilepsy
NEJM 365:919-26, Kwan, P.,et al, 2011

Multimodal Imaging Does Not Delay Intravenous Thrombolytic Therapy in Acute Stroke
AJNR 32:864-68, Salottolo, K.M.,et al, 2011

An unusual cause of stroke and hypoxia
BMJ 342:c7200, Bell, S.L. & Eveson, D.J., 2011

Diagnosing Cerebral Aneuryms by Computed Tomographic Angiography: Meta-Analysis
Ann Neurol 69:646-654, Menke, J.,et al, 2011

Population-based study of wake-up strokes
Neurol 76:1662-1667, Mackey, J.,et al, 2011

Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy
Neurol 76:1555-1563, French, J.A.,et al, 2011

Helicopter Transport of Stroke Patients and Its Influence on Thrombolysis Rates
Stroke 42:1295-1300, Reiner-Deitemyer, V.,et al, 2011

Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data
Pharmacol Ther 129:185-194, Terry, K.W.,et al, 2011

Folic acid supplementation prevents phenytoin-induced gingival overgrowth in children
Neurol 76:1338-1343, Arya, R.,et al, 2011

Prevalence of MRI-defined recent silent ischemia and associated bleeding risk with thrombolysis
Neurol 76:1288-1295, Tisserand, M.,et al, 2011

Diagnosis and management of transient ischaemic attack and ischaemic stroke in the acute phase
BMJ 342:d1938, McArthur, K.S.,et al, 2011

VGKC antibodies in pediatric encephalitis presenting with status epilepticus
Neurology 76:1252-1255, Suleiman, J.,et al, 2011

Are all IV thrombolysis exclusion criteria necessary? Being SMART about evidence-based medicine
Neurol 76:1780-1781, Tong, D., 2011

Safety and Outcomes of Intravenous Thrombolysis in Stroke Mimics
Stroke 42:1771-1774, Tsivgoulis, G.,et al, 2011

Comparison of IVIg and PLEX in patients with myasthenia gravis
Neurol 76:2017-2023, Barth, D.,et al, 2011

Intravenous Thrombolytic Therapy for Acute Ischemic Stroke
NEJM 364:22, Wechsler, L.R., 2011

Intravenous Thrombolysis in Nonagenarians With Ischemic Stroke
Stroke 42:1967-1970, Sarikaya, H.,et al, 2011

Intravenous thrombolysis in acute ischaemic stroke: a systematic review and meta-analysis to aid decision making in patients over 80 years of age
JNNP 82:712-717, Bhatnagar, P.,et al, 2011

Long-Term Mortality in Childhood-Onset Epilepsy
NEJM 363:2522-2529, Sillanp��,M. &Shinnar,S., 2010

A Diagnostic and Therapeutic Scheme for a Solitary Cysticercus Granuloma
Neurol 75:2236-2245, Singh,G.,et al, 2010

Intrauterine Exposure to Carbamazepine and Specific Congenital Malformations: Systematic Review and Case-Control Study
BMJ 341:c6581, 1229, Jentik,J.,et al, 2010

Personalized Approaches to Clopidogrel Therapy: Are We There Yet?
Stroke 41:2997-3002, Anderson,C.D.,et al, 2010



Showing articles 500 to 550 of 2784 << Previous Next >>